Cointime

Refuge Biotechnologies

company

About

Refuge Biotechnologies therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.

  • 101 - 250

Highlights

Total Funding Amount
$25M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series B
Last Funding Money Raised
$25M
Industries
Biotechnology,Genetics,Health Care,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
101 - 250
Operating Status
Active

Refuge is a cancer immunotherapy company leveraging synthetic biology and gene engineering to unlock the full promise of cell therapies. We create cell therapies that sense their surroundings and conditionally activate or repress multiple genes simultaneously – resulting in more potent and targeted treatments beyond a single target and function.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$25M
Refuge Biotechnologies has raised a total of $25M in funding over 2 rounds. Their latest funding was raised on May 2, 2018 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 2, 2018 Series B $25M 2 3sbio — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Refuge Biotechnologies is funded by 2 investors. 3sbio and Ocean Pine Healthcare Fund are the most recent investors.
Investor Name Lead Investor Funding Round
3sbio Yes Series B
Ocean Pine Healthcare Fund — Series B
Cointime
เนื้อหา
บริษัท